Nordic Expansion Recent distribution agreement with Medikro Oy to offer Trudell’s drug free Aerobika OPEP devices in Finland and Sweden signals a clear path for Nordic market expansion; leverage this channel to reach hospitals, clinics and respiratory care programs with focused clinician education, regional regulatory alignment, and co branded marketing to drive adoption of non pharmacologic airway therapies.

RDx Synergy The asset sale of Vyaire Medical’s RDx unit to Trudell Medical International opens opportunities to cross sell integrated respiratory solutions and tap into RDx customer relationships; propose bundled offerings that combine Aerobika devices with RDx data or asset management services and targeted outreach to existing RDx users across hospitals and therapy centers.

Home Care Push Past collaborations on portable nebulizers indicate potential to expand into home use respiratory devices and portable therapy solutions; target COPD, asthma and post acute patients through home care programs, durable medical equipment channels, and payer sponsored initiatives that favor drug free devices.

Value Based Selling Trudell emphasizes patient outcomes and health system savings, creating a strong ROI story for hospitals and payers; develop clinical and economic evidence, ROI calculators, and procurement ready materials to support value based purchasing and reduce total cost of care across respiratory care pathways.

Manufacturing Scale With a mid sized manufacturing footprint and demonstrated capacity growth, there is an opportunity to pursue OEM and private label partnerships or contract manufacturing for other pharma and medical device brands seeking respiratory devices, leveraging existing quality systems and production capabilities to accelerate time to market for new products.